We serve Chemical Name:3-Methylbenzoyl isothiocyanate CAS:28115-86-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:3-Methylbenzoyl isothiocyanate
CAS.NO:28115-86-8
Synonyms:3-methylbenzoyl isothiocyanate
Molecular Formula:C9H7NOS
Molecular Weight:177.22300
HS Code:2930909090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:285.7ºC at 760mmHg
Density:1.11g/cm3
Index of Refraction:1.576
PSA:61.52000
Exact Mass:177.02500
LogP:2.23800
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:UN 2810
Packing Group:
Contact us for information like 3-methylbenzoyl isothiocyanate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3-methylbenzoyl isothiocyanate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3-methylbenzoyl isothiocyanate Use and application,3-methylbenzoyl isothiocyanate technical grade,usp/ep/jp grade.
Related News: Although biocatalysis is globally acknowledged to be a valuable means of ensuring greener, more sustainable manufacturing, its implementation has reached stasis after increasing steadily for the past 10 – 15 years. 1,1-dichlorosilolane manufacturers The results provided a formulation amenable to two dosage strengths by applying a proportional dosing weight method.” The product is currently in late-stage development with the New Drug Application filing expected in late 2021. barium benzoate suppliers I look forward to working alongside such an ambitious team who are passionate about using cutting-edge technology to solve the health issues of the future and meet the needs of pharma and biotech companies across the globe.” 2-(Chloromethyl)naphthalene vendor & factory GSK picked McNamara after six months of “extensive search and selection process,” GSK said in its announcement Thursday. It ran the quest with help from two headhunters and evaluated “several external and internal candidates,” it said.,Soliris would need a “substantial discount” to reach a more appropriate price, according to its report. Using the widely leveraged measure for disease burden known as quality-adjusted life year (QALY), ICER calculated a range of $6,900 to achieve $50,000 per QALY to $25,700 to hit $200,000 per QALY.
